H
Heron Therapeutics, Inc. (HRTX)
NCM – Real Time Price. Currency in USD
0.96
+0.01 (0.93%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.96
+0.01 (0.93%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.48 | 6.05 | 10 | |
| Quick ratio | 1.51 | 5.63 | 8.0 | |
| Debt to Equity | 9.81 | 0.30 | 2.0 | |
| Debt to Assets | 0.21 | 1.04 | 8.0 | |
| Interest coverage | 0.00 | -16.91 | 2.0 | |
| Weighted average score | 6.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 108M | 127M | 144M | 155M | 155M |
| Gross Profit | 53M | 62M | 106M | 114M | 114M |
| Operating Income | -169M | -111M | -12M | -3M | -2M |
| Net Income | -182M | -111M | -14M | -20M | -20M |
| EBITDA | -166M | -108M | -9M | -224K | 276K |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -5.62 | -333.33 | 1.0 |
| Next quarter | 14.87 | 66.67 | 9.0 |
| Current year | 12.8 | 77.78 | 9.0 |
| Next year | 20.41 | 549.99 | 10 |
| Weighted average score | 7.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.22 | 83.12 | 80 | -790 | 6.5 |
| Y/Y | -0.46 | -180.63 | -199.99 | 26.04 | 3.3 |
| 3y average | 12.97 | 26.09 | 35.84 | 34.71 | 9.5 |
| 5y average | 12.21 | 19.74 | 28.68 | 24.87 | 9.0 |
| Weighted average score | 7.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $140.6M significantly exceeds cash reserves ($28.6M), raising financial stability concerns
Total current assets $238.1M exceed Total current liabilities $96.1M, highlighting excellent liquidity
Debt-to-equity ratio (9.8) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (0.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$9.2M limits the company's ability to reinvest or pay down debt